+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Oral Proteins and Peptides Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024

  • ID: 4757182
  • Report
  • January 2019
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

FEATURED COMPANIES

  • Allergan Plc.
  • AstraZeneca PLC
  • Biocon Limited
  • Chiasma Inc.
  • Novo Nordisk A/S
  • Proxima Concepts Limited
  • MORE
The report on the global oral proteins and peptides market provides qualitative and quantitative analysis for the period from 2016 to 2024. The report predicts the global oral proteins and peptides market to grow with a CAGR of 12.6% over the forecast period from 2018-2024. The study on oral proteins and peptides market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.

The report on oral proteins and peptides market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global oral proteins and peptides market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global oral proteins and peptides market over the period of 2016 to 2024. Further, the author's growth matrix given in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1. Drivers
  • Improvement in healthcare infrastructure
  • Increase in prevalence of chronic diseases
  • Increase in geriatric population
2. Restraints
  • High costs connected with drug development
3. Opportunities
  • Growth in purchasing power in emerging countries
Research Methodology

Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Primary research respondents typically include:

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

Secondary sources of the data typically include:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segments Covered

The global oral proteins and peptides market is segmented on the basis of drug type, and application.

The Global Oral Proteins and Peptides Market by Drug Type
  • Octreotide
  • Linaclotide
  • Insulin
  • Plecanatide
  • Calcitonin
The Global Oral Proteins and Peptides Market by Application
  • Hormonal Disorders
  • Gastric & Digestive Disorders
  • Diabetes
  • Bone Diseases
Company Profiles

The companies covered in the report include:
  • Chiasma Inc.
  • Allergan Plc.
  • Biocon Limited
  • Generex Biotechnology Corp.
  • Oramed Pharmaceuticals Inc.
  • Synergy Pharmaceuticals Inc.
  • AstraZeneca PLC
  • Novo Nordisk A/S
  • Proxima Concepts Limited
  • Tarsa Therapeutics Inc.
What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the oral proteins and peptides market.
2. Complete coverage of all the segments in the oral proteins and peptides market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in the global oral proteins and peptides market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. The growth matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan Plc.
  • AstraZeneca PLC
  • Biocon Limited
  • Chiasma Inc.
  • Novo Nordisk A/S
  • Proxima Concepts Limited
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Oral Proteins and Peptides Market Highlights
2.2. Oral Proteins and Peptides Market Projection
2.3. Oral Proteins and Peptides Market Regional Highlights

3. Global Oral Proteins and Peptides Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Drug Type
3.4.2. Growth Matrix Analysis by Application
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Oral Proteins and Peptides Market

4. Oral Proteins and Peptides Market Macro Indicator Analysis

5. Global Oral Proteins and Peptides Market by Drug Type
5.1. Octreotide
5.2. Linaclotide
5.3. Insulin
5.4. Plecanatide
5.5. Calcitonin

6. Global Oral Proteins and Peptides Market by Application
6.1. Hormonal Disorders
6.2. Gastric & Digestive Disorders
6.3. Diabetes
6.4. Bone Diseases

7. Global Oral Proteins and Peptides Market by Region 2018-2024
7.1. North America
7.1.1. North America Oral Proteins and Peptides Market by Drug Type
7.1.2. North America Oral Proteins and Peptides Market by Application
7.1.3. North America Oral Proteins and Peptides Market by Country
7.2. Europe
7.2.1. Europe Oral Proteins and Peptides Market by Drug Type
7.2.2. Europe Oral Proteins and Peptides Market by Application
7.2.3. Europe Oral Proteins and Peptides Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Oral Proteins and Peptides Market by Drug Type
7.3.2. Asia-Pacific Oral Proteins and Peptides Market by Application
7.3.3. Asia-Pacific Oral Proteins and Peptides Market by Country
7.4. RoW
7.4.1. RoW Oral Proteins and Peptides Market by Drug Type
7.4.2. RoW Oral Proteins and Peptides Market by Application
7.4.3. RoW Oral Proteins and Peptides Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Oral Proteins and Peptides Market
8.2. Companies Profiles
8.2.1. Chiasma Inc.
8.2.2. Allergan Plc.
8.2.3. Biocon Limited
8.2.4. Generex Biotechnology Corp.
8.2.5. Oramed Pharmaceuticals Inc.
8.2.6. Synergy Pharmaceuticals Inc.
8.2.7. AstraZeneca PLC
8.2.8. Novo Nordisk A/S
8.2.9. Proxima Concepts Limited
8.2.10. Tarsa Therapeutics Inc.

9. Appendix
9.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Chiasma Inc.
  • Allergan Plc.
  • Biocon Limited
  • Generex Biotechnology Corp.
  • Oramed Pharmaceuticals Inc.
  • Synergy Pharmaceuticals Inc.
  • AstraZeneca PLC
  • Novo Nordisk A/S
  • Proxima Concepts Limited
  • Tarsa Therapeutics Inc.
Note: Product cover images may vary from those shown
Adroll
adroll